Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change
26-09-09	€0.6400	0.00%
26-09-08	€0.6400	0.00%
26-09-07	€0.6400	0.00%
26-09-04	€0.6400	0.00%
26-09-03	€0.6400	0.00%

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 11:55:00 2026-09-09 EDT			5-day change	1st Jan Change
0.6400 ^EUR	0.00%		0.00%	-63.43%

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 148K 120K 109K 205K 14.12M 206K 1.42M 550K 7.21M 557K 545K 22.75M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.41M 12.47M 11.37M 21.26M 1.47B 21.34M 148M 57.08M 748M 57.83M 56.57M 2.36B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALSAF	Real-time
Deutsche Boerse AG	OR9	Delayed
Börse Stuttgart	OR9	Delayed

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

Safe S.A. Stock

Stocks

ALSAF

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation : Safe S.A.

Chart: Safe S.A.

Latest news : Safe S.A.

Press Releases : Safe S.A.

News in other languages : Safe S.A.

Quotes and Performance

Price Extremes

Managers and Directors : Safe S.A.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

09-08	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-25	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

1 week	0.64	0.64
1 month	0.64	0.64
Current year	0.54	1.81
1 year	0.54	2.6
3 years	0.54	141,014.1
5 years	0.54	6,204,899,937.95
10 years	0.54	10,000,000,000

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	0.00%	0.00%	-73.33%	-100.00%	148K
STRYKER CORPORATION	-0.38%	-13.24%	-29.95%	-4.89%	106B
SMITH & NEPHEW PLC	-0.05%	-4.16%	-27.40%	-3.89%	11.69B
GLAUKOS CORPORATION	-2.84%	+1.75%	+95.68%	+141.72%	10.91B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-2.44%	-3.21%	-54.31%	-70.46%	4.18B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.83%	-2.87%	-30.91%	+35.95%	2.47B
INSIGHT LIFETECH CO., LTD.	-2.58%	-6.67%	-	-	1.93B
INSPIRE MEDICAL SYSTEMS, INC.	+6.98%	+8.06%	-20.43%	-70.39%	1.8B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-1.28%	-3.34%	-24.10%	-27.52%	1.57B
Average	-0.25%	-2.19%	-20.59%	-12.44%	15.62B
Weighted average by Cap.	+1.08%	-9.83%	-20.41%	+4.38%

	2024	2025
Net sales	5.04M 5.87M 4.75M 4.33M 8.1M 558M 8.13M 56.24M 21.73M 285M 22.02M 21.54M 899M	5.36M 6.24M 5.05M 4.61M 8.61M 594M 8.65M 59.84M 23.12M 303M 23.43M 22.92M 957M
Net income	-1.93B -2.25B -1.82B -1.66B -3.1B -214B -3.11B -21.52B -8.32B -109B -8.43B -8.24B -344B	-4.67M -5.44M -4.4M -4.01M -7.51M -517M -7.54M -52.14M -20.15M -264M -20.42M -19.97M -834M
Net Debt	11.47M 13.35M 10.81M 9.85M 18.42M 1.27B 18.49M 128M 49.45M 648M 50.11M 49.02M 2.05B	13.11M 15.26M 12.35M 11.26M 21.06M 1.45B 21.14M 146M 56.53M 741M 57.27M 56.03M 2.34B

3 months	+14.29%
6 months	-22.89%
Current year	-63.43%